Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
Jason Yerke, Seth R. Bauer, Stephanie Bass, Heather Torbic, Michael Militello, Sarah Welch, Department of Pharmacy, Cleveland Clinic, Cleveland, OH 44195, United States
Erin Roach, Department of Pharmacy, Carolinas Medical Center, Charlotte, NC 28203, United States
Ibrahim Hanouneh, Department of Gastroenterology, Mayo Clinic, Rochester, MN 55905, United States
Author contributions: Yerke J, Welch S, Bauer S, Bass S, Torbic H and Militello M conceived the research study design; Yerke J collected data; Yerke J and Welch S interpreted data; Yerke J drafted the manuscript; Yerke J, Welch S, Bauer S, Bass S, Torbic H, Militello M, Hanouneh I and Roach E critically revised the manuscript.
Supported by: Cleveland Clinic Department of Pharmacy.
Institutional review board statement: The study was reviewed and approved by the Cleveland Clinic Foundation Institutional Review Board.
Conflict-of-interest statement: Dr. Hanouneh reports personal fees from Merck and Co., personal fees from Dova Pharmaceuticals, personal fees from Gilead Sciences, Inc., outside the submitted work; all other authors report no potential conflicts of interest.
STROBE statement: The authors have read the STROBE statement checklist of items, and the manuscript was prepared and revised according to the STROBE statement checklist of items.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Jason Yerke, PharmD, Pharmacist, Department of Pharmacy, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States. email@example.com
Received: January 10, 2019
Peer-review started: January 10, 2019
First decision: March 5, 2019
Revised: March 22, 2019
Accepted: April 8, 2019
Article in press: April 8, 2019
Published online: April 27, 2019